Mechanisms in the in Vivo Release of Lymphokines. V. Responses in Alloxan-treated and Genetically Diabetic Mice
Overview
Cell Biology
Authors
Affiliations
SALVIN S, Tanner E Clin Exp Immunol. 1984; 55(1):133-9.
PMID: 6420098 PMC: 1535798.
Altered immune function in alloxan-induced diabetes in mice.
Glass E, Stewart J, WEIR D Clin Exp Immunol. 1986; 65(3):614-21.
PMID: 3780043 PMC: 1542511.
Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.
Drell D, Notkins A Diabetologia. 1987; 30(3):132-43.
PMID: 3556288 DOI: 10.1007/BF00274217.
Handwerger B, Fernandes G, Riehm T, Yoon J, Sutherland D, Brown D Clin Exp Immunol. 1985; 60(1):145-50.
PMID: 2988831 PMC: 1576997.
Antidiabetic effects of interleukin 1.
Del Rey A, Besedovsky H Proc Natl Acad Sci U S A. 1989; 86(15):5943-7.
PMID: 2668949 PMC: 297747. DOI: 10.1073/pnas.86.15.5943.